Cell Signaling Technology

PathScan® RP Phospho-RSK1 (Ser380) Sandwich ELISA Kit

#7965 · $678

100
Citing papers
8k
Combined citations
Supplier page Find this product

Research areas

PI3K/AKT/mTOR signaling in cancer15Cell death mechanisms and regulation12Cancer Cells and Metastasis10Cancer-related Molecular Pathways9Tuberous Sclerosis Complex Research6TGF-β signaling in diseases6Cancer-related molecular mechanisms research5NF-κB Signaling Pathways5

Papers citing this product

1
Hypoxia-inducible Factor 1α Is Regulated by the Mammalian Target of Rapamycin (mTOR) via an mTOR Signaling Motif
Journal of Biological Chemistry·2007·491 cit.·DOI
2
Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model
Journal of Clinical Investigation·2008·387 cit.·DOI
3
Rheb Binding to Mammalian Target of Rapamycin (mTOR) Is Regulated by Amino Acid Sufficiency
Journal of Biological Chemistry·2005·346 cit.·DOI
4
GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Aβ42
The EMBO Journal·2007·283 cit.·DOI
5
mTOR signaling regulates central and peripheral circadian clock function
PLoS Genetics·2018·199 cit.·DOI
6
Hypothalamic bile acid-TGR5 signaling protects from obesity
Cell Metabolism·2021·193 cit.·DOI
7
SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial–mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer
Cell Death and Disease·2021·187 cit.·DOI
8
Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02
Neuro-Oncology·2014·166 cit.·DOI
9
Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53
The EMBO Journal·2007·161 cit.·DOI
10
Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide
Neuro-Oncology·2011·158 cit.·DOI